Gregory Licholai
Overview
Gregory Licholai received an average of $434K in total compensation, including $235K in salary, at Amicus Therapeutics from 2006 to 2008.
Source: SEC filing on April 24, 2009.
Related executives
We found 13 more executives who work or worked at Amicus Therapeutics.
John Crowley
Amicus Therapeutics
Chief Executive Officer
Bradley Campbell
Amicus Therapeutics
Chief Operating Officer
Jay Barth
Amicus Therapeutics
Chief Medical Officer
William Baird
Amicus Therapeutics
Chief Financial Officer
Kenneth Peist
Amicus Therapeutics
Vice president, legal and intellectual property
David Lockhart
Amicus Therapeutics
Chief Scientific Officer
Joan Winterbottom
Amicus Therapeutics
Senior vice president, Human Resources
Pol Boudes
Amicus Therapeutics